These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 2680503)

  • 1. Ventricular arrhythmias: control of therapy by Holter monitoring.
    Horowitz LN
    Eur Heart J; 1989 Sep; 10 Suppl E():53-60. PubMed ID: 2680503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Programmed stimulation in patients with malignant ventricular arrhythmias. I: Diagnostic value].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Feb; 9(1):45-51. PubMed ID: 6200414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death: etiologies, pathogenesis, and management.
    Kremers MS; Black WH; Wells PJ
    Dis Mon; 1989 Jun; 35(6):381-445. PubMed ID: 2656164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antiarrhythmic therapy using Holter monitoring.
    Morganroth J
    Am J Cardiol; 1988 Oct; 62(12):18H-23H. PubMed ID: 3052004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sudden death risk factors in acute and chronic coronary artery disease.
    Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Noninvasive versus invasive procedure in patients with life threatening tachyarrhythmias].
    Andresen D
    Herz; 1990 Feb; 15(1):42-8. PubMed ID: 2179088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications.
    Surawicz B
    J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience.
    Bigger JT
    Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular arrhythmias and sudden death in children.
    Garson A; Smith RT; Moak JP; Ross BA; McNamara DG
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):130B-133B. PubMed ID: 3998329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exercise testing in the assessment of ventricular arrhythmias (author's transl)].
    Kafka W; Petri H; Rudolph W
    Herz; 1982 Jun; 7(3):140-3. PubMed ID: 6178669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Repetitive ventricular response by programmed electrostimulation of the heart: frequency and clinical significance].
    Meinertz T; Treese N; Kasper W; Pop T
    Herz; 1984 Feb; 9(1):34-44. PubMed ID: 6706284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late potentials, myocardial kinetics and ventricular vulnerability as markers of sudden death after myocardial infarct].
    D'Aulerio M; Gronda M; Prando MD; Occhetta E; Makmur J; Rossi L; Rossi P
    G Ital Cardiol; 1986 Feb; 16(2):114-26. PubMed ID: 3721103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias.
    Morganroth J
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):669-73. PubMed ID: 2076377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to manage the post-MI patient with ventricular arrhythmias.
    Weinberg B; Zipes D
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III86-90. PubMed ID: 2691145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.